NSE · TTKHLTCARE · Healthcare
TTK Healthcare Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
No disclosed results available.
Shareholding
No shareholding disclosed.
Promoter holding trend
Each disclosed period, oldest to newest
Not enough history.
52-week position
Where the current price sits in its yearly band
The band spans 1.78× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
AI analysis
AI-generated · google/gemini-2.5-flashTTK Healthcare Ltd. (symbol: 507747) operates in various segments including animal welfare, consumer products, medical devices, protective devices, food, and others. The company reported a market capitalization of Rs 1431 Cr and revenue of Rs 857.28 Cr. Its profit margin stands at 7.66%.
Positives
- +The company's debt-to-equity ratio is low at 0.02.
- +Promoter shareholding is substantial at 74.56% as of Jun 2026.
- +There are no reported promoter share pledges.
- +Net profit increased from Rs 62.84 Cr in Mar 2024 to Rs 81.66 Cr in Mar 2025.
- +EPS increased from Rs 44.47 in Mar 2024 to Rs 57.79 in Mar 2025.
Negatives
- −ROE is 5.89% and ROCE is 7.50%, indicating moderate returns.
- −While annual profit increased, quarterly net profit showed fluctuation, decreasing from Rs 20.39 Cr in Sep 2025 to Rs 10.53 Cr in Dec 2025.
- −Profit margin is 7.66%, which may be considered moderate.
Business Overview
TTK Healthcare Ltd. operates across diverse sectors. Its Animal Welfare segment offers veterinary products and supplements. The Consumer Products segment includes baby care (Woodward's Gripe water), personal care (EVA), and home care (Good Home) products. The Medical Devices segment manufactures artificial heart valves (TTK Chitra) and orthopedic implants. The Protective Devices segment focuses on sexual wellness products under the Skore brand. The Foods segment produces papads (Fryums) and other food items, while the Others segment covers publishing maps and educational materials. The company was established in 1928 and is headquartered in Chennai.
Financial Performance
TTK Healthcare Ltd. reported a revenue of Rs 872.75 Cr in Mar 2025, an increase from Rs 815.40 Cr in Mar 2024. Net profit also rose from Rs 62.84 Cr in Mar 2024 to Rs 81.66 Cr in Mar 2025. The company's EPS grew from Rs 44.47 in Mar 2024 to Rs 57.79 in Mar 2025. Over the last four quarters (Mar 2025 to Dec 2025), the company's net profit showed fluctuations, with Rs 16.15 Cr in Mar 2025, Rs 13 Cr in Jun 2025, Rs 20.39 Cr in Sept 2025, and Rs 10.53 Cr in Dec 2025.
Profitability & Returns
The company's profit margin was 7.66%. It recorded a Return on Equity (ROE) of 5.89% and a Return on Capital Employed (ROCE) of 7.50%. Earnings Per Share (EPS) for the latest reported period stands at Rs 48.6. Annual EPS has increased from Rs 44.47 in Mar 2024 to Rs 57.79 in Mar 2025.
Balance Sheet Indicators
TTK Healthcare Ltd. has a book value of Rs 785.85. The debt-to-equity ratio is 0.02, indicating a low reliance on debt. The company reports no pledged promoter shares.
Ownership & Pledges
As of Jun 2026, promoters held 74.56% of the shares. Public shareholding was 21.39%, while FIIs held 1.86% and DIIs held 2.19%. Institutional holdings accounted for 4.05%. The company has reported no promoter share pledges.
Data as of — price: 2026-07-29 · financials: not disclosed · shareholding: not disclosed. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.